75
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: Absorption/Malabsorption

In vivo Influence of Nicotine on Human Basal and NSAID-induced Gut Barrier Function

, , , , , , & show all
Pages 399-408 | Received 26 Aug 2002, Accepted 21 Jan 2003, Published online: 27 Feb 2017

References

  • Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811–5.
  • Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997; 126: 364–71.
  • Guslandi M, Tittobello A. Outcome of ulcerative colitis after treatment with transdermal nicotine. Eur J Gastroenterol Hepatol 1998; 10: 513–5.
  • Sandborn WJ, Tremaine WJ, Leighton JA, Lawson GM, Zins BJ, Compton RF, et al. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Aliment Pharmacol Ther 1997; 11: 663–71.
  • Green JT, Thomas GA, Rhodes J, Williams GT, Evans BK, Russell MA, et al. Nicotine enemas for active ulcerative colitis: pilot study. Aliment Pharmacol Ther 1997; 11: 859–63.
  • Russel MGV, Volovicx A, Schoon EJ, Van Wijlick EHJ, Logan RF, et al, and the European Collaborative IBD Study Group., Inflammatory bowel diseases: is there any relation between smoking status and disease presentation? Inflamm Bowel Dis 1998; 4: 182–6.
  • Prytz H, Benoni C, Tagesson C. Does smoking tighten the gut? Scand J Gastroenterol 1989; 24: 1084–8.
  • Benoni C, Prytz H. Effects of smoking on the urine excretion of oral 51Cr-EDTA in ulcerative colitis. Gut 1998; 42: 656–8.
  • Blomquist L, Bark T, Hedenborg G, Svenberg T, Norman A. Comparison between the lactulose/mannitol and 51Cr-EDTA/14C-mannitol methods for intestinal permeability. Scand J Gastroenterology 1993; 28: 274–80.
  • Suenaert P, Bulteel V, Den Hond E, Hiele M, Peeters M, Monsuur F, et al. Smoking and the indomethacin-induced increase of small intestinal permeability. Aliment Pharmacol Ther 2000; 14: 819–22.
  • Wong PW, Kadakia SC, McBiles M. Acute effect of nicotine patch on gastric emptying of liquid and solid contents in healthy subjects. Dig Dis Sci 1999; 44: 2165–71.
  • Gritz ER, Ippoliti A, Jarvik ME, Rose JE, Shiffman S, Harrison A, et al. The effect of nicotine on the delay of gastric emptying. Aliment Pharmacol Ther 1988; 2: 173–8.
  • Rausch T, Beglinger C, Alam N, Gyr K, Meier R. Effect of transdermal application of nicotine on colonic transit in healthy nonsmoking volunteers. Neurogastroenterol Mot 1998; 10: 263–70.
  • Bjarnason I, Williams P, So A, Zanelli G, Levi A, Gumpel J, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 1: 1171–4.
  • Teahon K, Somasundaram S, Smith T, Menzies I, Bjarnason I. Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. Gut 1996; 38: 864–9.
  • Sigthorsson G, Tibbie J, Hayllar J, Menzies I, Macpherson A, Moots R, et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998; 43: 506–11.
  • Bjarnason I, Maxton D, Reynolds AP, Catt S, Peters TJ, Menzies I. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterology 1994; 29: 630–9.
  • Meddings JB, Sutherland L, Byles N, Wallace J. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104: 1619–26.
  • Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clin Sci 1992; 82: 471–88.
  • Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566–81.
  • Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998; 114: 83–92.
  • Enns R, Bak A, Meddings JB, Sutherland LR. Sucralose: a novel permeability marker for colonic disease. Gastroenterology 1997; 112: A967.
  • Jenkins AP, Trew DR, Crump BJ, Nukajam WS, Foley JA, Menzies IS, et al. Do non-steroidal anti-inflammatory drugs increase colonic permeability? Gut 1991; 32: 66–9.
  • Bjarnason I, Smethurst P, Clark P, Menzies I, Levi J, Peters T. Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man. Scand J Gastroenterol 1989; Suppl 164: 97–102.
  • Peeters M, Hiele M, Ghoos Y, Hyusmans V, Geboes K, Vantrappen G. Test conditions greatly influence permeation of water soluble molecules through intestinal mucosa: need for standardisation. Gut 1994; 35: 1404–8.
  • Oman H, Blomquist L, Henriksson A, Johansson S. Comparison of polysucrose 15000, 51Cr-EDTA, and 14C-mannitol as markers of intestinal permeability in man. Scand J Gastroenterol 1995; 30: 1172–7.
  • Monsuur F, Geypens B, Bulteel V, Luypaerts A, Suenaert P, Rutgeerts P, et al. Determination of sucralose in urine by GC- FID. Abstract and article on the Twenty-third International Symposium on Capillary Chromatography, Riva Del Garda, May 2000 Website: www.richrom.com/html/iocd_1.html (Biomedical and Pharmaceutical Applications, L.06).
  • Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 1640–7.
  • Geypens B, Bennink R, Peeters M, Evenepoel P, Mortelmans L, Maes B, et al. Validation of the lactose-[13C]ureide breath test for determination of orocaecal transit time by scintigraphy. J Nucl Med 1999; 40: 1451–5.
  • Geypens Benny, Maes B, Ghoos Y, Luypaerts A, Rutgeerts P. Correlation of ileal emptying and gastric emptying calculated from a simultaneous application of two breath tests. Gastroenterology 1998; 114: A755.
  • Sayer B, Lu J, Green C, Soderholm JD, Akhtar M, McKay DM. Dextran sodium sulphate-induced colitis perturbs muscarinic cholinergic control of epithelial ion transport. Br J Pharmacol 2002; 135: 1794–800.
  • Louvet B, Buisine M, Desreumaux P, Tremaine W, Aubert J, Porchet N, et al. Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in UC. Inflamm Bowel Dis 1999; 5: 174–81.
  • Eliakim RE, Fan QX, Babyatsky W. Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur J Gastroenterol Hepatol 2002; 14: 607–14.
  • Srivastava ED, Hallett MB, Rhodes J. Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers. Hum Toxicol 1989; 8: 461–3.
  • Van Dijk AP, Meijssen MA, Brouwer AJ, Hop WC, Van Bergeijk JD, Feyerabend C, et al. Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers. Eur J Clin Invest 1998; 28: 664–71.
  • Sher M, Bank S, Greenberg R, Sardinha C, Weissman S, Bailey B, et al. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 1999; 5:73–8.
  • Aldhous M, Stark LA, Dunlp M, Satsangi J. Effect of nicotine on spontaneous and LPS-induced NF-κB activation in SW480 cell line. Gastroenterology 2002; 122: A334.
  • Van Dijk JP, Madretsma GS, Keuskamp ZJ, Zijlstra FJ. Nicotine inhibits cytokine synthesis by mouse colonic mucosa. Eur J Pharmacol 1995; 278: R11–2.
  • Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Fich A. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis. Eur J Gastroenterol Hepatol 1998; 10: 1013–9.
  • Galeazzi F, Blennerhassett P, Qiu B, O'Byrne P, Collins S. Cigarette smoke aggravates experimental colitis in rats. Gastroenterology 1999; 117: 877–83.
  • Guo X, Wang W, Ko J, Cho C. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology 1999; 117: 884–92.
  • Davies N. Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment Pharmacol Ther 1998; 12: 303–20.
  • Smecuol E, Bai J, Sugai E, Vazquez H, Niveloni S, Pedreira S, et al. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001 49: 650–5.
  • Nowak A, Jonderko K, Kaczor R, Nowak S, Skrzypek D. Cigarette smoking delays gastric emptying of a radiolabeled solid food in healthy smokers. Scand J Gastroenterol 1987; 22: 54–8.
  • Scott AM, Kellow JE, Eckersley GM, Nolan JM, Jones MP. Cigarette smoking and nicotine delay postprandial mouth-cecum transit time. Dig Dis Sci 1992; 37: 1544–7.
  • Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau JA, Van Der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995; 108: 687–96.
  • Hallbäck D-A, Hulten L, Jodal M, Lindhagen J, Lundgren O. Evidence for the existence of a countercurrent exchanger in the small intestine in man. Gastroenterology 1978; 74: 683–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.